Swiss National Bank Syndax Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 149,400 shares of SNDX stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,400

Previous 150,600 0.8%

Holding current value

$1.95 Million

Previous $3.09 Million 6.99%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$17.93 - $24.81 $21,516 - $29,772	-1,200 Reduced 0.8%	149,400 $2.88 Million
Q1 2024 May 07, 2024	BUY	$19.71 - $24.57 $161,622 - $201,474	8,200 Added 5.76%	150,600 $3.58 Million
Q4 2023 Feb 06, 2024	BUY	$11.39 - $21.67 $243,746 - $463,738	21,400 Added 17.69%	142,400 $3.08 Million
Q3 2023 Nov 08, 2023	BUY	$14.52 - $21.77 $24,684 - $37,009	1,700 Added 1.42%	121,000 $1.76 Million
Q2 2023 Aug 09, 2023	BUY	$19.35 - $22.31 $69,660 - $80,316	3,600 Added 3.11%	119,300 $2.5 Million
Q1 2023 May 10, 2023	SELL	$20.66 - $28.98 $283,042 - $397,026	-13,700 Reduced 10.59%	115,700 $2.44 Million
Q4 2022 Feb 08, 2023	BUY	$20.64 - $26.24 $332,304 - $422,464	16,100 Added 14.21%	129,400 $3.29 Million
Q3 2022 Nov 09, 2022	BUY	$18.51 - $24.79 $149,931 - $200,799	8,100 Added 7.7%	113,300 $2.72 Million
Q2 2022 Aug 09, 2022	BUY	$13.64 - $19.48 $160,952 - $229,864	11,800 Added 12.63%	105,200 $2.02 Million
Q1 2022 May 09, 2022	BUY	$14.84 - $22.15 $120,204 - $179,415	8,100 Added 9.5%	93,400 $1.62 Million
Q3 2021 Nov 08, 2021	BUY	$13.87 - $19.8 $30,514 - $43,560	2,200 Added 2.65%	85,300 $1.63 Million
Q2 2021 Aug 06, 2021	BUY	$13.42 - $25.18 $120,780 - $226,620	9,000 Added 12.15%	83,100 $1.43 Million
Q1 2021 May 07, 2021	BUY	$19.28 - $24.59 $17,352 - $22,131	900 Added 1.23%	74,100 $1.66 Million
Q4 2020 Feb 05, 2021	BUY	$15.1 - $26.44 $1.11 Million - $1.94 Million	73,200 New	73,200 $1.63 Million

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Syndax Pharmaceuticals Inc Transaction History